We are international
Donate
TEXT SIZE   


KOS 2007: The Role of Donor-Lymphocyte Infusion and Other Post-Transplant Strategies After Allografting in Multiple Myeloma
Nikolaus Kröger
06.28.07

AUTHORS: N. Kröger1, F. Ayuk1, D. Atanackovic2, A. Zander1
1 Dept. of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Germany
2 Dept. of Oncology and Hematology, University Hospital Hamburg-Eppendorf, Germany

Donor-lymphocyte infusions (DLI) provide effective treatment for patients who experienced relapse after allogeneic stem cell transplantation. Meanwhile the graft-versus-myeloma effect of DLI is well established. Several attempts had been made in the last years to improve the efficacy of DLI after allogeneic stem cell transplantation for multiple myeloma.


 related articles